Governor Newsom has signed Assembly Bill 1883, introducing sweeping new restrictions on how employers may use artificial intelligence-powered surveillance tools. The legislation, known as AB 1883, directly targets the growing use of
Ronaldo has shared fresh photographs of his extraordinary car collection on Instagram, captioning the post simply “my toys” for his millions of followers. The Al-Nassr striker, aged 41, has previously admitted to
More
Roivant Sciences (ROIV) and its partner Priovant Therapeutics have secured FDA approval for Lisraya, a first-in-class oral treatment for the rare autoimmune disease dermatomyositis. The U.S. Food and Drug Administration approved Lisraya,
More
Wells Fargo’s Legal Specialty Group has released its six-month 2026 survey, and the headline numbers show Biglaw enjoying one of its strongest years on record. Revenue across the Am Law 200 climbed
More
Colman’s Mustard is being put up for sale by its parent company Unilever as part of a sweeping merger between the FTSE 100 giant’s food division and US spice giant McCormick. Bankers
More
Dividend investors are increasingly turning their attention to high-yield stocks that appear undervalued when measured against forward earnings expectations for 2027. In an environment where interest rates remain a key concern for
More
Gilead Sciences has secured regulatory approval from the US Food and Drug Administration for Bixlenvo, a new once-daily single-tablet HIV treatment combining two established compounds. The pill pairs bictegravir, the active backbone
More
The US Department of Justice has reached a $400 million settlement with TikTok, ByteDance, and affiliated entities over violations of children’s online privacy laws. The settlement resolves litigation concerning compliance with the
More
London’s blue-chip index closed sharply lower on Thursday as investor anxiety over inflation and interest rates overshadowed a powerful rally in technology stocks driven by Nvidia. The FTSE 100 ended the session
More
Cleveland Federal Reserve President Beth Hammack has renewed her call for higher interest rates, warning the central bank remains too far from its inflation target. Speaking at the Fed’s annual symposium in
More
Revolution Medicines (RVMD) is pushing forward with the commercial launch of daraxonrasib, branded as Rasonque, following a landmark approval from the US Food and Drug Administration. The drug represents a historic milestone
More